




Searching News Database: Boehringer Ingelheim
HSMN NewsFeed - 9 Jan 2023
Boehringer Ingelheim and 3T Biosciences Join Forces to Develop Next-Generation Cancer Immunotherapies
Boehringer Ingelheim and 3T Biosciences Join Forces to Develop Next-Generation Cancer Immunotherapies
HSMN NewsFeed - 23 Jul 2021
ImaginAb Announces Extension Of Long-Standing Partnership With Boehringer Ingelheim
ImaginAb Announces Extension Of Long-Standing Partnership With Boehringer Ingelheim
HSMN NewsFeed - 18 Jun 2021
Nuevocor closes US$24M Series A Financing to Advance Novel Gene Therapies for Cardiomyopathies
Nuevocor closes US$24M Series A Financing to Advance Novel Gene Therapies for Cardiomyopathies
HSMN NewsFeed - 30 Oct 2020
Yew Looi Liew Named President of U.S. Human Pharma for Boehringer Ingelheim Pharmaceuticals, Inc.
Yew Looi Liew Named President of U.S. Human Pharma for Boehringer Ingelheim Pharmaceuticals, Inc.
HSMN NewsFeed - 10 Aug 2020
NBE-Therapeutics Appoints Erich Schlick as Chairman of the Board of Directors
NBE-Therapeutics Appoints Erich Schlick as Chairman of the Board of Directors
HSMN NewsFeed - 19 Dec 2019
Metabomed Completes a $12.5 Million Raise in Order to Advance Its Lead Program Into Clinical Studies
Metabomed Completes a $12.5 Million Raise in Order to Advance Its Lead Program Into Clinical Studies
HSMN NewsFeed - 10 Oct 2019
FDA Grants Ofev(R) Breakthrough Therapy Designation for Chronic Fibrosing ILDs with a Progressive Phenotype
FDA Grants Ofev(R) Breakthrough Therapy Designation for Chronic Fibrosing ILDs with a Progressive Phenotype
HSMN NewsFeed - 26 Jun 2019
U.S. FDA Grants Fast Track Designation to Empagliflozin for the Treatment of Chronic Heart Failure
U.S. FDA Grants Fast Track Designation to Empagliflozin for the Treatment of Chronic Heart Failure
HSMN NewsFeed - 14 May 2019
Boehringer Ingelheim announces resolution of Cyltezo(R) patent litigation
Boehringer Ingelheim announces resolution of Cyltezo(R) patent litigation
HSMN NewsFeed - 14 May 2019
AbbVie Resolves HUMIRA(R) (adalimumab) U.S. Patent Litigation with Boehringer Ingelheim
AbbVie Resolves HUMIRA(R) (adalimumab) U.S. Patent Litigation with Boehringer Ingelheim
HSMN NewsFeed - 27 Mar 2019
Lannett Receives FDA Approval For Aspirin And Extended-Release Dipyridamole Capsules, 25 mg/200 mg
Lannett Receives FDA Approval For Aspirin And Extended-Release Dipyridamole Capsules, 25 mg/200 mg
HSMN NewsFeed - 4 Oct 2017
Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary
Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary
HSMN NewsFeed - 24 Mar 2017
Reata Pharmaceuticals, Inc. Appoints David Chapman as Vice President, Marketing
Reata Pharmaceuticals, Inc. Appoints David Chapman as Vice President, Marketing
HSMN NewsFeed - 24 Oct 2016
Efficacy of Ofev(R) (nintedanib) Reinforced in Range of Patients with IPF in New Analyses Presented at CHEST
Efficacy of Ofev(R) (nintedanib) Reinforced in Range of Patients with IPF in New Analyses Presented at CHEST
HSMN NewsFeed - 15 Sep 2016
Eyevensys Announces Series A Extension Bringing Total Capital Raised to €9 Million
Eyevensys Announces Series A Extension Bringing Total Capital Raised to €9 Million
HSMN NewsFeed - 15 Aug 2016
Arena Pharmaceuticals Announces Appointment of Vincent Aurentz as Chief Business Officer
Arena Pharmaceuticals Announces Appointment of Vincent Aurentz as Chief Business Officer
HSMN NewsFeed - 13 Jul 2016
Lilly and Boehringer Ingelheim Announce Clinical Trial Collaboration in Metastatic Breast Cancer
Lilly and Boehringer Ingelheim Announce Clinical Trial Collaboration in Metastatic Breast Cancer
HSMN NewsFeed - 20 Aug 2015
S1 Biopharma Supports FDA Approval of First-Ever Treatment for Hypoactive Sexual Desire Disorder
S1 Biopharma Supports FDA Approval of First-Ever Treatment for Hypoactive Sexual Desire Disorder
HSMN NewsFeed - 29 Jun 2015
Aerie Pharmaceuticals Elects Julie McHugh and Michael M. du Toit to the Company’s Board of Directors
Aerie Pharmaceuticals Elects Julie McHugh and Michael M. du Toit to the Company’s Board of Directors
HSMN NewsFeed - 7 Apr 2014
Deciphera Pharmaceuticals Appoints Michael D. Taylor, Ph.D., as President and Chief Executive Officer
Deciphera Pharmaceuticals Appoints Michael D. Taylor, Ph.D., as President and Chief Executive Officer
HSMN NewsFeed - 31 Jan 2014
Eli Lilly and Company Provides Statement in Response to Sanofi U.S. Lawsuit
Eli Lilly and Company Provides Statement in Response to Sanofi U.S. Lawsuit
HSMN NewsFeed - 3 Sep 2013
Amakem Appoints Jean Marie Stassen as Vice President, Research and Development
Amakem Appoints Jean Marie Stassen as Vice President, Research and Development
HSMN NewsFeed - 26 Feb 2013
Cytori Appoints Dr. Steven Kesten as Executive Vice President and Chief Medical Officer
Cytori Appoints Dr. Steven Kesten as Executive Vice President and Chief Medical Officer
HSMN NewsFeed - 10 Dec 2012
TransCelerate BioPharma Inc. Appoints Dalvir Gill as Chief Executive Officer
TransCelerate BioPharma Inc. Appoints Dalvir Gill as Chief Executive Officer
HSMN NewsFeed - 21 Mar 2012
Jerry St. Peter appointed Executive Vice President and General Manager of NicOx Inc.
Jerry St. Peter appointed Executive Vice President and General Manager of NicOx Inc.
HSMN NewsFeed - 8 Mar 2012
S1 Pharmaceuticals Announces New Executive Management and Scientific Advisory Board Appointments
S1 Pharmaceuticals Announces New Executive Management and Scientific Advisory Board Appointments
HSMN NewsFeed - 17 Jan 2012
Aerocrine appoints pulmonologist Paul Dorinsky, M.D., as medical director, North America
Aerocrine appoints pulmonologist Paul Dorinsky, M.D., as medical director, North America
HSMN NewsFeed - 5 Dec 2011
Micromet Appoints Joseph Lobacki Senior Vice President and Chief Commercial Officer
Micromet Appoints Joseph Lobacki Senior Vice President and Chief Commercial Officer
HSMN NewsFeed - 31 Aug 2011
Selecta Biosciences Appoints Takashi Kei Kishimoto, Ph.D., as Chief Scientific Officer
Selecta Biosciences Appoints Takashi Kei Kishimoto, Ph.D., as Chief Scientific Officer
HSMN NewsFeed - 14 Jun 2011
Micromet Appoints Ulrich Grau, Ph.D. Executive Vice President and Chief Operating Officer
Micromet Appoints Ulrich Grau, Ph.D. Executive Vice President and Chief Operating Officer
HSMN NewsFeed - 14 Jan 2011
Orexo and Invida Jointly Announce Agreement for Abstral(TM) in Asia Pacific
Orexo and Invida Jointly Announce Agreement for Abstral(TM) in Asia Pacific
HSMN NewsFeed - 10 Jan 2011
Exelixis’ XL184 Granted Orphan Drug Designation and Assigned the Generic Name Cabozantinib
Exelixis’ XL184 Granted Orphan Drug Designation and Assigned the Generic Name Cabozantinib
HSMN NewsFeed - 10 Jan 2011
Orexo: FDA Approval For Abstral (Fentanyl) Sublingual Tablets - US Launch Planned For Q1 2011
Orexo: FDA Approval For Abstral (Fentanyl) Sublingual Tablets - US Launch Planned For Q1 2011
HSMN NewsFeed - 4 Aug 2010
Watson Names Sigurdur Oli Olafsson Executive Vice President, Global Generics
Watson Names Sigurdur Oli Olafsson Executive Vice President, Global Generics
HSMN NewsFeed - 26 May 2010
Pfizer Appoints Mikael Dolsten President of Worldwide Research and Development
Pfizer Appoints Mikael Dolsten President of Worldwide Research and Development
HSMN NewsFeed - 19 Apr 2010
Roxane Laboratories, Inc. Announces the Launch of Imipramine Pamoate Capsules
Roxane Laboratories, Inc. Announces the Launch of Imipramine Pamoate Capsules
HSMN NewsFeed - 23 Mar 2010
Once-Daily MIRAPEX ER Now Approved by FDA for Both Early and Advanced Parkinson's Disease
Once-Daily MIRAPEX ER Now Approved by FDA for Both Early and Advanced Parkinson's Disease
HSMN NewsFeed - 22 Feb 2010
FDA Approves Once-Daily MIRAPEX ER for the Treatment of Early Parkinson's Disease
FDA Approves Once-Daily MIRAPEX ER for the Treatment of Early Parkinson's Disease
HSMN NewsFeed - 25 Jan 2010
Acorda Therapeutics Announces Lauren Sabella Joins as Executive Vice President of Commercial Development
Acorda Therapeutics Announces Lauren Sabella Joins as Executive Vice President of Commercial Development
HSMN NewsFeed - 8 Jan 2010
Industry Veteran Ron Branning Joins Genzyme to Lead Global Product Quality
Industry Veteran Ron Branning Joins Genzyme to Lead Global Product Quality
HSMN NewsFeed - 17 Dec 2009
FDA Approves SPIRIVA(R) HandiHaler(R) for the Reduction of COPD Exacerbations
FDA Approves SPIRIVA(R) HandiHaler(R) for the Reduction of COPD Exacerbations
HSMN NewsFeed - 7 Dec 2009
Xencor Appoints Former ZymoGenetics CEO, Bruce Carter, to Chairman of the Board
Xencor Appoints Former ZymoGenetics CEO, Bruce Carter, to Chairman of the Board
HSMN NewsFeed - 19 Nov 2009
Anika Therapeutics Receives European CE Mark Approval for "ELEVESS Light"
Anika Therapeutics Receives European CE Mark Approval for "ELEVESS Light"
HSMN NewsFeed - 14 Oct 2009
XOMA Appoints Susan Kramer, Dr. P.H. Vice President of Project and Alliance Management
XOMA Appoints Susan Kramer, Dr. P.H. Vice President of Project and Alliance Management
HSMN NewsFeed - 5 Oct 2009
Impax Laboratories Receives Tentative FDA Approval for Generic FLOMAX(R) 0.4mg Capsules
Impax Laboratories Receives Tentative FDA Approval for Generic FLOMAX(R) 0.4mg Capsules
HSMN NewsFeed - 18 Aug 2009
Par Pharmaceutical & Aveva Drug Delivery Systems Receive Final Approval to Market Generic Catapres TTS(R)
Par Pharmaceutical & Aveva Drug Delivery Systems Receive Final Approval to Market Generic Catapres TTS(R)
HSMN NewsFeed - 28 Jul 2009
Laureate Pharma Appoints Daniel E. Leone as Vice President of Business Development
Laureate Pharma Appoints Daniel E. Leone as Vice President of Business Development
HSMN NewsFeed - 21 May 2009
Budesonide/Formoterol Plus Tiotropium Improves the Quality of Life of Patients With Severe COPD
Budesonide/Formoterol Plus Tiotropium Improves the Quality of Life of Patients With Severe COPD
HSMN NewsFeed - 30 Mar 2009
BrainCells Inc. Appoints Philip Jochelson, M.D. Chief Medical Officer and Jason Levin Chief Business Officer
BrainCells Inc. Appoints Philip Jochelson, M.D. Chief Medical Officer and Jason Levin Chief Business Officer
HSMN NewsFeed - 2 Mar 2009
Orexo's AbstralTM Receives Two Further Large EU Market Approvals in France and Spain
Orexo's AbstralTM Receives Two Further Large EU Market Approvals in France and Spain
HSMN NewsFeed - 17 Feb 2009
Break-through Drug for Heart Failure in Dogs Now Available in the United States
Break-through Drug for Heart Failure in Dogs Now Available in the United States
HSMN NewsFeed - 10 Dec 2008
Study Showed New Episodes of Depression Delayed in People Taking Cymbalta(R)
Study Showed New Episodes of Depression Delayed in People Taking Cymbalta(R)
HSMN NewsFeed - 10 Dec 2008
MorphoSys Appoints Dr. Arndt Schottelius as Chief Development Officer and Member of the Management Board
MorphoSys Appoints Dr. Arndt Schottelius as Chief Development Officer and Member of the Management Board
HSMN NewsFeed - 26 Nov 2008
MorphoSys and Galapagos Enter Alliance to Co-develop Novel Therapeutic Antibodies in Bone and Joint Disease
MorphoSys and Galapagos Enter Alliance to Co-develop Novel Therapeutic Antibodies in Bone and Joint Disease
HSMN NewsFeed - 24 Sep 2008
Nice Approves Pradaxa(R)*(Dabigatran Etexilate) - First New Oral Anticoagulant in the UK for Over 50 Years
Nice Approves Pradaxa(R)*(Dabigatran Etexilate) - First New Oral Anticoagulant in the UK for Over 50 Years
HSMN NewsFeed - 22 Aug 2008
Cymbalta Receives European Approval for the Treatment of Generalised Anxiety Disorder
Cymbalta Receives European Approval for the Treatment of Generalised Anxiety Disorder
HSMN NewsFeed - 31 Jul 2008
Orexo and ProStrakan Extend Licensing Agreement for Rapinyl/Abstral and change Partner in North America
Orexo and ProStrakan Extend Licensing Agreement for Rapinyl/Abstral and change Partner in North America
HSMN NewsFeed - 8 Jul 2008
Anika Therapeutics Announces Exclusive U.S. Distribution Agreement for Elevess Injectable Dermal Filler
Anika Therapeutics Announces Exclusive U.S. Distribution Agreement for Elevess Injectable Dermal Filler
HSMN NewsFeed - 30 Jun 2008
Anika Therapeutics Announces Commercial Availability of MONOVISC(TM) in Europe
Anika Therapeutics Announces Commercial Availability of MONOVISC(TM) in Europe
HSMN NewsFeed - 27 Jun 2008
European CHMP Issues Positive Opinion on Cymbalta for the Treatment of Generalised Anxiety Disorder
European CHMP Issues Positive Opinion on Cymbalta for the Treatment of Generalised Anxiety Disorder
HSMN NewsFeed - 16 Jun 2008
OncoMed Pharmaceuticals Extends License Agreement for Use of MorphoSys's Core Technology
OncoMed Pharmaceuticals Extends License Agreement for Use of MorphoSys's Core Technology
HSMN NewsFeed - 24 Apr 2008
Lannett Company Receives Approval for Dipyridamole Tablets USP, 25 mg, 50 mg, and 75 mg
Lannett Company Receives Approval for Dipyridamole Tablets USP, 25 mg, 50 mg, and 75 mg
HSMN NewsFeed - 21 Apr 2008
Nephros Strengthens Commercialization Team with Addition of Marketing Executive
Nephros Strengthens Commercialization Team with Addition of Marketing Executive
HSMN NewsFeed - 27 Mar 2008
Novel Oral Anticoagulant Pradaxa(R) (dabigatran etexilate) Approved by the European Commission
Novel Oral Anticoagulant Pradaxa(R) (dabigatran etexilate) Approved by the European Commission
HSMN NewsFeed - 19 Feb 2008
Barr Receives Final Approval for Generic Mirapex(R) Tablets, 0.125mg, 0.25mg, 0.5mg, 1mg & 1.5mg
Barr Receives Final Approval for Generic Mirapex(R) Tablets, 0.125mg, 0.25mg, 0.5mg, 1mg & 1.5mg
HSMN NewsFeed - 29 Jan 2008
Anika Therapeutics Appoints Andrew J. Carter, Ph.D., as Chief Technology Officer
Anika Therapeutics Appoints Andrew J. Carter, Ph.D., as Chief Technology Officer
HSMN NewsFeed - 19 Dec 2007
Curis, Inc. Announces Appointment of Stephen K. Carter, M.D. to its Board of Directors
Curis, Inc. Announces Appointment of Stephen K. Carter, M.D. to its Board of Directors
HSMN NewsFeed - 20 Nov 2007
Anika Therapeutics and Galderma Agree to Terminate License, Development and Supply Agreements
Anika Therapeutics and Galderma Agree to Terminate License, Development and Supply Agreements
HSMN NewsFeed - 8 Nov 2007
Astellas and Boehringer Ingelheim Reach Settlement Agreement with Ranbaxy on Flomax Patent Case
Astellas and Boehringer Ingelheim Reach Settlement Agreement with Ranbaxy on Flomax Patent Case
HSMN NewsFeed - 18 Sep 2007
Anika Therapeutics Promotes Randall Wilhoite to Vice President-Operations
Anika Therapeutics Promotes Randall Wilhoite to Vice President-Operations
HSMN NewsFeed - 2 May 2007
Penwest Names Amale Hawi Senior Vice President, Pharmaceutical Development
Penwest Names Amale Hawi Senior Vice President, Pharmaceutical Development
HSMN NewsFeed - 24 Apr 2007
Roxane Laboratories, Inc. Announces Launch of Zolpidem Tartrate Tablets CIV, 5mg and 10mg
Roxane Laboratories, Inc. Announces Launch of Zolpidem Tartrate Tablets CIV, 5mg and 10mg
HSMN NewsFeed - 16 Apr 2007
Ipsen Appoints Sean McKercher as Vice President of Commercial Development in North America
Ipsen Appoints Sean McKercher as Vice President of Commercial Development in North America
HSMN NewsFeed - 7 Feb 2007
Anavex Life Sciences Corp. Appoints VP Business Development and VP Strategic Planning
Anavex Life Sciences Corp. Appoints VP Business Development and VP Strategic Planning
HSMN NewsFeed - 25 Jan 2007
Spectrum Pharmaceuticals Initiates Phase 2b Trial for Ozarelix in Patients with Benign Prostate Hypertrophy
Spectrum Pharmaceuticals Initiates Phase 2b Trial for Ozarelix in Patients with Benign Prostate Hypertrophy
HSMN NewsFeed - 21 Dec 2006
Anika Therapeutics Receives FDA Approval for Its Cosmetic Tissue Augmentation Product
Anika Therapeutics Receives FDA Approval for Its Cosmetic Tissue Augmentation Product
HSMN NewsFeed - 27 Nov 2006
Biota and Boehringer Ingelheim Complete US$102 Million License for HCV Program
Biota and Boehringer Ingelheim Complete US$102 Million License for HCV Program
HSMN NewsFeed - 13 Nov 2006
Anika Therapeutics Appoints Constance Garrison as Vice President of Regulatory and Clinical Affairs
Anika Therapeutics Appoints Constance Garrison as Vice President of Regulatory and Clinical Affairs
HSMN NewsFeed - 10 Nov 2006
FDA Approves MIRAPEX for the Treatment of Moderate-to-Severe Primary Restless Legs Syndrome
FDA Approves MIRAPEX for the Treatment of Moderate-to-Severe Primary Restless Legs Syndrome
HSMN NewsFeed - 31 Oct 2006
Boehringer Ingelheim Launches PROUD Study to Explore Possible Disease-Modifying Effect of Pramipexole
Boehringer Ingelheim Launches PROUD Study to Explore Possible Disease-Modifying Effect of Pramipexole
HSMN NewsFeed - 3 Oct 2006
Archemix Strengthens Management With Appointment of James Gilbert, M.D., as Chief Medical Officer
Archemix Strengthens Management With Appointment of James Gilbert, M.D., as Chief Medical Officer
HSMN NewsFeed - 24 Aug 2006
Pramipexole Safe and Effective in Treating Restless Legs Syndrome, Study Shows
Pramipexole Safe and Effective in Treating Restless Legs Syndrome, Study Shows
HSMN NewsFeed - 23 Aug 2006
New Study of Depressive Symptoms in Parkinson's Disease Patients Shows Positive Results for Mirapex
New Study of Depressive Symptoms in Parkinson's Disease Patients Shows Positive Results for Mirapex
HSMN NewsFeed - 14 Aug 2006
Schering-Plough Appoints Trevor Juniper General Manager, Schering-Plough China
Schering-Plough Appoints Trevor Juniper General Manager, Schering-Plough China
HSMN NewsFeed - 19 Jul 2006
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Mobic(R)
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Mobic(R)
HSMN NewsFeed - 4 May 2006
ImmunoGen, Inc. to Develop Commercial-Scale Manufacturing Process for Trastuzumab-DM1 for Genentech
ImmunoGen, Inc. to Develop Commercial-Scale Manufacturing Process for Trastuzumab-DM1 for Genentech
HSMN NewsFeed - 1 May 2006
Altus Pharmaceuticals Appoints Lauren Sabella Vice President, Commercial Development
Altus Pharmaceuticals Appoints Lauren Sabella Vice President, Commercial Development
HSMN NewsFeed - 5 Apr 2006
Pramipexole Significantly Improved Symptoms of Restless Legs Syndrome, New Studies Show
Pramipexole Significantly Improved Symptoms of Restless Legs Syndrome, New Studies Show
HSMN NewsFeed - 7 Mar 2006
Roxane Laboratories, Inc. Resumes Shipments of Fluticasone Propionate Nasal Spray, 50 mcg
Roxane Laboratories, Inc. Resumes Shipments of Fluticasone Propionate Nasal Spray, 50 mcg
Additional items found! 131

Members Archive contains
131 additional stories matching:
Boehringer Ingelheim
(Password required)
Boehringer Ingelheim
(Password required)